AIMS/HYPOTHESIS: We examined whether retinal vessel diameter in persons with type 1 diabetes mellitus is associated with changes in subclinical anatomical and functional indicators of diabetic nephropathy. METHODS:Persons with type 1 diabetes mellitus had gradable fundus photographs and renal biopsy data at baseline and 5-year follow-up (n = 234). Retinal arteriolar and venular diameters were measured at baseline and follow-up. Central retinal arteriole equivalent (CRAE) and central retinal venule equivalent (CRVE) were computed. Baseline and 5-year follow-up renal structural variables were assessed by masked electron microscopic morphometric analyses from percutaneous renal biopsy specimens. Variables assessed included: mesangial fractional volume, glomerular basement membrane width, mesangial matrix fractional volume and glomerular basement membrane width composite glomerulopathy index. RESULTS: While controlling for other covariates, baseline CRAE was positively associated with change in the glomerulopathy index over the 5-year period. Change in CRAE was inversely related to a change in mesangial matrix fractional volume and abnormal mesangial matrix fractional volume, while change in CRVE was directly related to change in the volume fraction of cortex that was interstitium [Vv((Int/cortex))] over the 5-year period. Baseline CRAE or CRVE or changes in these diameters were not related to changes in other anatomical or functional renal endpoints. CONCLUSIONS/ INTERPRETATION: Independently of other factors, baseline CRAE correlated with changes in glomerulopathy index, a composite measure of extracellular matrix accumulation in the mesangium and glomerular basement membrane. A narrowing of the CRAE was related to mesangial matrix accumulation. Changes in CRVE were related to changes in Vv((Int/cortex),) a measure of interstitial expansion in persons with type 1 diabetes mellitus.
RCT Entities:
AIMS/HYPOTHESIS: We examined whether retinal vessel diameter in persons with type 1 diabetes mellitus is associated with changes in subclinical anatomical and functional indicators of diabetic nephropathy. METHODS:Persons with type 1 diabetes mellitus had gradable fundus photographs and renal biopsy data at baseline and 5-year follow-up (n = 234). Retinal arteriolar and venular diameters were measured at baseline and follow-up. Central retinal arteriole equivalent (CRAE) and central retinal venule equivalent (CRVE) were computed. Baseline and 5-year follow-up renal structural variables were assessed by masked electron microscopic morphometric analyses from percutaneous renal biopsy specimens. Variables assessed included: mesangial fractional volume, glomerular basement membrane width, mesangial matrix fractional volume and glomerular basement membrane width composite glomerulopathy index. RESULTS: While controlling for other covariates, baseline CRAE was positively associated with change in the glomerulopathy index over the 5-year period. Change in CRAE was inversely related to a change in mesangial matrix fractional volume and abnormal mesangial matrix fractional volume, while change in CRVE was directly related to change in the volume fraction of cortex that was interstitium [Vv((Int/cortex))] over the 5-year period. Baseline CRAE or CRVE or changes in these diameters were not related to changes in other anatomical or functional renal endpoints. CONCLUSIONS/ INTERPRETATION: Independently of other factors, baseline CRAE correlated with changes in glomerulopathy index, a composite measure of extracellular matrix accumulation in the mesangium and glomerular basement membrane. A narrowing of the CRAE was related to mesangial matrix accumulation. Changes in CRVE were related to changes in Vv((Int/cortex),) a measure of interstitial expansion in persons with type 1 diabetes mellitus.
Authors: Avi Katz; Maria Luiza A Caramori; Susan Sisson-Ross; Thomas Groppoli; John M Basgen; Michael Mauer Journal: Kidney Int Date: 2002-06 Impact factor: 10.612
Authors: L D Hubbard; R J Brothers; W N King; L X Clegg; R Klein; L S Cooper; A R Sharrett; M D Davis; J Cai Journal: Ophthalmology Date: 1999-12 Impact factor: 12.079
Authors: J R Williamson; K Chang; M Frangos; K S Hasan; Y Ido; T Kawamura; J R Nyengaard; M van den Enden; C Kilo; R G Tilton Journal: Diabetes Date: 1993-06 Impact factor: 9.461
Authors: Martin Ritt; Joanna M Harazny; Christian Ott; Markus P Schneider; Markus P Schlaich; Georg Michelson; Roland E Schmieder Journal: J Hypertens Date: 2009-11 Impact factor: 4.844
Authors: Michael Mauer; Bernard Zinman; Robert Gardiner; Samy Suissa; Alan Sinaiko; Trudy Strand; Keith Drummond; Sandra Donnelly; Paul Goodyer; Marie Claire Gubler; Ronald Klein Journal: N Engl J Med Date: 2009-07-02 Impact factor: 91.245
Authors: Luenda E Charles; Ja K Gu; Claudia C Ma; Lisa M Grady; Anna Mnatsakanova; Michael E Andrew; Desta Fekedulegn; John M Violanti; Ronald Klein Journal: J Occup Environ Med Date: 2017-10 Impact factor: 2.162
Authors: Ja K Gu; Luenda E Charles; Ronald Klein; Lisa M Grady; Claudia C Ma; Penelope Allison; John M Violanti; Michael E Andrew Journal: J Occup Environ Med Date: 2018-03 Impact factor: 2.162
Authors: Joshua A Wood; Nihar M Shah; Clayton T McKee; Marissa L Hughbanks; Sara J Liliensiek; Paul Russell; Christopher J Murphy Journal: Biomaterials Date: 2011-04-17 Impact factor: 12.479
Authors: Joanne Wen Yee Yau; Jing Xie; Ryo Kawasaki; Holly Kramer; Michael Shlipak; Ronald Klein; Barbara Klein; Mary Frances Cotch; Tien Yin Wong Journal: Am J Kidney Dis Date: 2011-05-06 Impact factor: 8.860
Authors: Stella Awua-Larbi; Tien Y Wong; Mary Frances Cotch; Ramon Durazo-Arvizu; David R Jacobs; Barbara E K Klein; Ronald Klein; Joao Lima; Kiang Liu; Holly Kramer Journal: Nephrol Dial Transplant Date: 2011-03-11 Impact factor: 5.992
Authors: Stephen A Burns; Ann E Elsner; Kaitlyn A Sapoznik; Raymond L Warner; Thomas J Gast Journal: Prog Retin Eye Res Date: 2018-08-27 Impact factor: 21.198